LMO2 and acute lymphoblastic leukemia: Our data are therefore consistent with a model whereby LMO2 is under the control of homeobox genes such as HOXA5 acting through the +1 enhancer to mediate ectopic expression in a subset of T-ALL patients with immature phenotype.